Aims The AARDVARK (Aortic Aneurysmal Regression of Dilation: Value of ACE-Inhibition
on RisK) trial investigated whether ACE-inhibition reduces small abdominal aortic …

OBJECTIVES: To evaluate whether either angiotensin converting enzyme (ACE) inhibitors
or other classes of antihypertensive drug attenuate or increase growth rates of small …

Abdominal aortic aneurysm (AAA) causes∼ 170 000 deaths annually worldwide. Most
guidelines recommend asymptomatic small AAAs (30 to< 50 mm in women; 30 to< 55 mm in …

Background Pharmacotherapy may represent a potential means to limit the expansion rate
of abdominal aortic aneurysms (AAAs). Studies evaluating the efficacy of different …

Abdominal aortic aneurysm is a common condition that may be lethal when it is
unrecognized. Current guidelines suggest repair as the aneurysm diameter reaches 5.0 to …

Background No effective treatment is currently available to prevent progression of small and
medium-sized abdominal aortic aneurysms (AAAs). Identification of drugs with sufficient …

Background: The present study was carried out in order to examine those factors that
influence the rate of expansion of small abdominal aortic aneurysms. Methods: A …

BACKGROUND: To study the propranolol treatment of small abdominal aortic aneurysms
(AAA) concerning intention to treat, side effects, and inhibition of expansion. METHODS …

Importance Currently there is no drug therapy for abdominal aortic aneurysm (AAA).
Objective To test the efficacy of the angiotensin receptor blocker telmisartan in slowing AAA …

Background Surveillance is a common management strategy for small abdominal aortic
aneurysm (AAA)(3· 0–5· 4 cm in diameter). Individual characteristics, other than diameter …